340 related articles for article (PubMed ID: 30673906)
1. Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.
Nishimuta H; Watanabe T; Bando K
AAPS J; 2019 Jan; 21(2):20. PubMed ID: 30673906
[TBL] [Abstract][Full Text] [Related]
2. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs.
Nishimuta H; Houston JB; Galetin A
Drug Metab Dispos; 2014 Sep; 42(9):1522-31. PubMed ID: 24994071
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches.
Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
J Pharm Sci; 2017 Sep; 106(9):2678-2687. PubMed ID: 28238896
[TBL] [Abstract][Full Text] [Related]
4. Uridine 5'-Diphospho-glucuronosyltransferase 1A3 (UGT1A3) Prediction of Hepatic Clearance of Organic Anion Transporting Polypeptide 1B3 (OATP1B3) Substrate Telmisartan by Glucuronidation Using In Vitro-In Vivo Extrapolation (IVIVE).
Gabor-Worwa E; Kowal-Chwast A; Gaud N; Gogola D; Littlewood P; Smoluch M; Brzózka K; Kus K
Eur J Drug Metab Pharmacokinet; 2024 May; 49(3):393-403. PubMed ID: 38642299
[TBL] [Abstract][Full Text] [Related]
5. Challenges and Opportunities for In Vitro-In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation.
Izat N; Bolleddula J; Abbasi A; Cheruzel L; Jones RS; Moss D; Ortega-Muro F; Parmentier Y; Peterkin VC; Tian DD; Venkatakrishnan K; Zientek MA; Barber J; Houston JB; Galetin A; Scotcher D
Drug Metab Dispos; 2023 Dec; 51(12):1591-1606. PubMed ID: 37751998
[TBL] [Abstract][Full Text] [Related]
6. A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry.
Crouch RD; Hutzler JM; Daniels JS
Xenobiotica; 2018 Mar; 48(3):219-231. PubMed ID: 28281401
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Organic Anion Transporting Polypeptide-Mediated Clearance in the Beagle Dog: Assessing In Vitro-In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human Clearance.
Matsunaga N; Ufuk A; Morse BL; Bedwell DW; Bao J; Mohutsky MA; Hillgren KM; Hall SD; Houston JB; Galetin A
Drug Metab Dispos; 2019 Mar; 47(3):215-226. PubMed ID: 30593544
[TBL] [Abstract][Full Text] [Related]
8. Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake.
Fujino R; Hashizume K; Aoyama S; Maeda K; Ito K; Toshimoto K; Lee W; Ninomiya SI; Sugiyama Y
Eur J Pharm Sci; 2018 Dec; 125():181-192. PubMed ID: 30287410
[TBL] [Abstract][Full Text] [Related]
9. Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver.
Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
Drug Metab Dispos; 2012 Feb; 40(2):322-8. PubMed ID: 22048522
[TBL] [Abstract][Full Text] [Related]
10. A quantitative approach to hepatic clearance prediction of metabolism by aldehyde oxidase using custom pooled hepatocytes.
Akabane T; Gerst N; Masters JN; Tamura K
Xenobiotica; 2012 Sep; 42(9):863-71. PubMed ID: 22448773
[TBL] [Abstract][Full Text] [Related]
11. Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.
Hultman Ia; Vedin C; Abrahamsson A; Winiwarter S; Darnell M
Mol Pharm; 2016 Aug; 13(8):2796-807. PubMed ID: 27377099
[TBL] [Abstract][Full Text] [Related]
12. Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.
Argikar UA; Potter PM; Hutzler JM; Marathe PH
AAPS J; 2016 Nov; 18(6):1391-1405. PubMed ID: 27495117
[TBL] [Abstract][Full Text] [Related]
13.
Morita K; Kato M; Kudo T; Ito K
Xenobiotica; 2020 Sep; 50(9):1064-1075. PubMed ID: 32125203
[No Abstract] [Full Text] [Related]
14. Evaluation of the Disconnect between Hepatocyte and Microsome Intrinsic Clearance and In Vitro In Vivo Extrapolation Performance.
Williamson B; Harlfinger S; McGinnity DF
Drug Metab Dispos; 2020 Nov; 48(11):1137-1146. PubMed ID: 32847864
[TBL] [Abstract][Full Text] [Related]
15. Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes.
Wegler C; Matsson P; Krogstad V; Urdzik J; Christensen H; Andersson TB; Artursson P
Mol Pharm; 2021 Apr; 18(4):1792-1805. PubMed ID: 33739838
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Hepatic Uptake in Human and Monkey Hepatocytes in the Presence and Absence of Serum Protein and Its In Vitro to In Vivo Extrapolation.
Liang X; Park Y; DeForest N; Hao J; Zhao X; Niu C; Wang K; Smith B; Lai Y
Drug Metab Dispos; 2020 Dec; 48(12):1283-1292. PubMed ID: 33037043
[TBL] [Abstract][Full Text] [Related]
17. Prediction of hepatic and intestinal glucuronidation using in vitro-in vivo extrapolation.
Naritomi Y; Nakamori F; Furukawa T; Tabata K
Drug Metab Pharmacokinet; 2015 Feb; 30(1):21-9. PubMed ID: 25760528
[TBL] [Abstract][Full Text] [Related]
18. In vitro hepatic metabolism of cediranib, a potent vascular endothelial growth factor tyrosine kinase inhibitor: interspecies comparison and human enzymology.
Schulz-Utermoehl T; Spear M; Pollard CR; Pattison C; Rollison H; Sarda S; Ward M; Bushby N; Jordan A; Harrison M
Drug Metab Dispos; 2010 Oct; 38(10):1688-97. PubMed ID: 20634336
[TBL] [Abstract][Full Text] [Related]
19. Use of Segregated Hepatocyte Scaling Factors and Cross-Species Relationships to Resolve Clearance Dependence in the Prediction of Human Hepatic Clearance.
Hallifax D; Houston JB
Drug Metab Dispos; 2019 Mar; 47(3):320-327. PubMed ID: 30610004
[TBL] [Abstract][Full Text] [Related]
20. In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes.
Tess D; Chang GC; Keefer C; Carlo A; Jones R; Di L
AAPS J; 2023 Apr; 25(3):40. PubMed ID: 37052732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]